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   Objectives:      
1) To compare primary patency at 3 months and secondary patency rates at 24 months 
of Gore-Viatorr and Niti-S stents 
2) Which stent has the best primary patency rate? 
3) Compare clinical outcome of Gore-Viatorr and Niti-S stents 
Methods: 
All the patients who had undergone TIPS procedure with placement of Gore Viatorr 
stent in the Department of Radiology, CMC Vellore from 1999 onwards were 
included in the study. Also patients who needed TIPS/ DIPS and underwent Niti-S 
stent placement during August 2016 to July 2017 were prospectively analysed.  
Post TIPS monitoring of the patients was done. Regular included follow up of patients 
included clinical evaluation and Doppler findings.. Those diagnosed to have shunt 
malfunction in the form of shunt stenosis or shunt occlusion underwent. These 
patients with shunt revision were further followed up at regular intervals. 
  
Results:  
Out of total 81 patients 45 had Gore Viatorr and 36 had Niti-S stent placement.  
Technical and heamodynamic success was achieved in 100% of cases.  
Most common cause of portal hypertension was found to be Budd Chiari syndrome. 
Most common indication for TIPS was refractory ascites accounting for 60% of case 
followed by variceal bleeding accounting for 12 % of cases.  
Out of  total 81 patients 18 had shunt malfunction in the form of shunt stenosis or 
shunt occlusion. 9 patients belonged to Gore Viatorr group and 9 belonged to Niti-S 
group. Out of total 18 patients with shunt malfunction 7patients again developed shunt 
malfunction after the first successful revision. Out of these 6 belonged to Gore Viatorr 
Group and 1 belonged to Niti-S group.  
Primary patency rate of Gore Viatorr stent at 3 month, 6 month, 1 year and 2 years 
were 96.4%, 92.7%, 88.9%, 76.7% respectively. 
Primary patency rate of  Niti-S stent at 3 month, 6 month, 1 year and 2 years were 
80.8%, 70.7%, 50.5%, 37.9% respectively. 
Secondary patency rates of Gore-Viatorr at 3 month, 6 month,  1 year and 2 years 
were 96.9 %, 92.9%, 85.8%, 75.9% respectively. 
Secondary patency rates of  Niti-S stent at 1 year and at 2 years was 75%. 
 Conclusion: 
 
1) Primary patency rate of Gore-Viatorr at 3 months is 94.6 % and that of Niti-S is 
80.8%. 
2) Secondary patency rate of Gore Viatorr at 24 months is 76% and that of Niti-S is 
75%.  
3) Overall clinical outcome and primary patency rate of Gorre Viatorr stent is better 
than Niti-S stent. 
4) Secondary patency rates of Gore Viatorr and Niti-S at 24 months are similar. 
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